Jci_page_head_homepage_01 Jci_page_head_homepage_02
Stephanie A. Shore, Jeffrey M. Drazen
Published in Volume 112, Issue 4
J Clin Invest. 2003; 112(4):495 doi:10.1172/JCI19642
Abstract | Full text | PDF
Citation information

Total citations by year in CrossRef

Year: 2011 2009 2008 2007 2006 2005 2004 Total
Citations: 1 1 1 1 1 1 2 8

Citations to this article in CrossRef (8)

Title and authors Publication Year
Gastrin-releasing peptide blockade as a broad-spectrum anti-inflammatory therapy for asthma.
Shutang Zhou, Erin N Potts, Frank Cuttitta, W Michael Foster, Mary E Sunday
Proc. Natl. Acad. Sci. U.S.A. 2011
Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model.
Long P Nguyen, Rui Lin, Sergio Parra, Ozozoma Omoluabi, Nicola A Hanania, Michael J Tuvim, Brian J Knoll, Burton F Dickey, Richard A Bond
Proc. Natl. Acad. Sci. U.S.A. 2009
The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study.
Nicola A Hanania, Supria Singh, Rami El-Wali, Michael Flashner, Amie E Franklin, William J Garner, Burton F Dickey, Sergio Parra, Stephen Ruoss, Felix Shardonofsky, Brian J O'Connor, Clive Page, Richard A Bond
Pulmonary Pharmacology & Therapeutics 2008
β-Adrenergic receptor polymorphisms: relationship to the β-agonist controversy and clinical implications
D Robin Taylor
Expert Opin. Pharmacother. 2007
Pharmacogenomics of β2-agonist: key focus on signaling pathways
Pallav Bhatnagar, Randeep Guleria, Ritushree Kukreti
Pharmacogenomics 2006
Risk of severe asthma episodes predicted from fluctuation analysis of airway function
Urs Frey, Tanja Brodbeck, Arnab Majumdar, D. Robin Taylor, G. Ian Town, Michael Silverman, Béla Suki
Nature 2005
Long-Acting ??2-Adrenoceptor Agonists and Exercise-Induced Asthma
Sandra D Anderson, John D Brannan
Pediatric Drugs 2004
Single-Dose Agents in the Prevention of Exercise-Induced Asthma
Sandra D Anderson
Treatments in Respiratory Medicine 2004